Prescription drug · NDA AUTHORIZED GENERIC
Carbidopa and Levodopa NDC 70710-2140
Carbidopa 36.25 mg/1; Levodopa 145 mg/1 · Capsule, Extended release · Oral · Zydus Pharmaceuticals USA Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 70710-2140-1 | 70710214001 | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70710-2140-1)Marketed from Oct 20, 2025 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Carbidopa and Levodopa
- Generic name (nonproprietary)
- carbidopa and levodopa
- Active ingredients
- Carbidopa — 36.25 mg/1Levodopa — 145 mg/1
- Dosage form
- Capsule, Extended release
- Route
- Oral
- Product type
- Prescription drug
- Marketing category
- NDA authorized genericApplication NDA 203312
- Marketing start
- Listing expires
- Other FDA classes
- Aromatic (Chemical structure)
- Identifiers
- Product ID 70710-2140_9f66a828-7712-41a2-8380-682a3bbe50d6SPL ID 9f66a828-7712-41a2-8380-682a3bbe50d6SPL set ID 74e7f96b-de31-4e3c-b32d-11421b291d4eRxCUI 1600773, 1600775, 1600914, 1600916UNII 46627O600J, MNX7R8C5VO
- Pharmacologic class
- Aromatic Amino Acid
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N470710214001followed by a unit qualifier and the quantityPackage 70710-2140-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Carbidopa and levodopa extended-release capsules are indicated for the treatment of Parkinson's disease, post-encephalitic parkinsonism, and parkinsonism that may follow carbon monoxide intoxication or manganese intoxication. Carbidopa and levodopa extended-release capsule is a combination of carbidopa (an aromatic amino acid decarboxylation inhibitor) and levodopa (an aromatic amino acid) indicated for the treatment of Parkinson's disease, post-encephalitic parkinsonism, and parkinsonism that may follow carbon monoxide intoxication or manganese intoxication ( 1 )
Excerpt only. Read the full label for complete information.
Other NDCs under NDA 203312
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Rytarycarbidopa and levodopa | Levodopa 195 mg/1; Carbidopa hydrate 48.75 mg/1 | Capsule, Extended releaseOral | Amneal Pharmaceuticals LLC | 64896-663 |
| Rytarycarbidopa and levodopa | Levodopa 245 mg/1; Carbidopa hydrate 61.25 mg/1 | Capsule, Extended releaseOral | Amneal Pharmaceuticals LLC | 64896-664 |
| Rytarycarbidopa and levodopa | Levodopa 145 mg/1; Carbidopa hydrate 36.25 mg/1 | Capsule, Extended releaseOral | Amneal Pharmaceuticals LLC | 64896-662 |
| Rytarycarbidopa and levodopa | Levodopa 95 mg/1; Carbidopa hydrate 23.75 mg/1 | Capsule, Extended releaseOral | Amneal Pharmaceuticals LLC | 64896-661 |
| Carbidopa and Levodopa | Carbidopa 61.25 mg/1; Levodopa 245 mg/1 | Capsule, Extended releaseOral | Zydus Pharmaceuticals USA Inc. | 70710-2142 |
| Carbidopa and Levodopa | Carbidopa 23.75 mg/1; Levodopa 95 mg/1 | Capsule, Extended releaseOral | Zydus Pharmaceuticals USA Inc. | 70710-2139 |
| Carbidopa and Levodopa | Carbidopa 48.75 mg/1; Levodopa 195 mg/1 | Capsule, Extended releaseOral | Zydus Pharmaceuticals USA Inc. | 70710-2141 |
| Carbidopa and Levodopa | Carbidopa 61.25 mg/1; Levodopa 245 mg/1 | Capsule, Extended releaseOral | REMEDYREPACK INC. | 70518-4610 |
| Carbidopa and Levodopa | Carbidopa 23.75 mg/1; Levodopa 95 mg/1 | Capsule, Extended releaseOral | REMEDYREPACK INC. | 70518-4618 |
| Carbidopa and Levodopa | Carbidopa 48.75 mg/1; Levodopa 195 mg/1 | Capsule, Extended releaseOral | REMEDYREPACK INC. | 70518-4621 |
| Carbidopa and Levodopa | Carbidopa 36.25 mg/1; Levodopa 145 mg/1 | Capsule, Extended releaseOral | REMEDYREPACK INC. | 70518-4630 |